| Literature DB >> 12493072 |
Elise Whitley1, Jonathan Ball.
Abstract
The present review introduces nonparametric methods. Three of the more common nonparametric methods are described in detail, and the advantages and disadvantages of nonparametric versus parametric methods in general are discussed.Entities:
Mesh:
Year: 2002 PMID: 12493072 PMCID: PMC153434 DOI: 10.1186/cc1820
Source DB: PubMed Journal: Crit Care ISSN: 1364-8535 Impact factor: 9.097
Relative risk of mortality associated with developing acute renal failure as a complication of sepsis
| Study | Relative risk | Sign |
| 1 | 0.75 | - |
| 2 | 2.03 | + |
| 3 | 2.29 | + |
| 4 | 2.11 | + |
| 5 | 0.80 | - |
| 6 | 1.50 | + |
| 7 | 0.79 | - |
| 8 | 1.01 | + |
| 9 | 1.23 | + |
| 10 | 1.48 | + |
| 11 | 2.45 | + |
| 12 | 1.02 | + |
| 13 | 1.03 | + |
| 14 | 1.30 | + |
| 15 | 1.54 | + |
| 16 | 1.27 | + |
Figure 1Relative risk of mortality associated with developing acute renal failure as a complication of sepsis.
Steps required in performing the sign test
| Step | Details |
| 1 | State the null hypothesis and, in particular, the hypothesized value for comparison |
| 2 | Allocate a sign (+ or -) to each observation according to whether it is greater or less than the hypothesized value. (Observations exactly equal to the hypothesized value are dropped from the analysis) |
| 3 | Determine: |
| N+ = the number of observations greater than the hypothesized value | |
| N- = the number of observations less than the hypothesized value | |
| S = the smaller of N+ and N- | |
| 4 | Calculate an appropriate |
Critical values for the sign test with a sample size of 16
| 0.10 | 0.05 | 0.01 | |
| Critical value | 4 | 3 | 2 |
Central venous oxygen saturation on admission and 6 hours after admission
| SvO2 (%) | ||||
| Patient | On admission | 6 hours | Difference | Sign |
| 1 | 39.7 | 52.9 | 13.2 | + |
| 2 | 59.1 | 56.7 | -2.4 | - |
| 3 | 56.1 | 61.9 | 5.8 | + |
| 4 | 57.7 | 71.4 | 13.7 | + |
| 5 | 60.6 | 67.7 | 7.1 | + |
| 6 | 37.8 | 50.0 | 12.2 | + |
| 7 | 58.2 | 60.7 | 2.5 | + |
| 8 | 33.6 | 51.3 | 17.7 | + |
| 9 | 56.0 | 59.5 | 3.5 | + |
| 10 | 65.3 | 59.8 | -5.5 | - |
SvO2 = central venous oxygen saturation.
Steps required in performing the Wilcoxon signed rank test
| Step | Details |
| 1 | State the null hypothesis and, in particular, the hypothesized value for comparison |
| 2 | Rank all observations in increasing order of magnitude, ignoring their sign. Ignore any observations that are equal to the hypothesized value. If two observations have the same magnitude, regardless of sign, then they are given an average ranking |
| 3 | Allocate a sign (+ or -) to each observation according to whether it is greater or less than the hypothesized value (as in the sign test) |
| 4 | Calculate: |
| R+ = sum of all positive ranks | |
| R- = sum of all negative ranks | |
| R = smaller of R+ and R- | |
| 5 | Calculate an appropriate |
Central venous oxygen saturation on admission and 6 hours after admission
| SvO2 (%) | |||||
| Patient | On admission | At 6 hours | Difference | Rank | Sign |
| 2 | 59.1 | 56.7 | -2.4 | 1 | - |
| 7 | 58.2 | 60.7 | 2.5 | 2 | + |
| 9 | 56.0 | 59.5 | 3.5 | 3 | + |
| 10 | 65.3 | 59.8 | -5.5 | 4 | - |
| 3 | 56.1 | 61.9 | 5.8 | 5 | + |
| 5 | 60.6 | 67.7 | 7.1 | 6 | + |
| 6 | 37.8 | 50.0 | 12.2 | 7 | + |
| 1 | 39.7 | 52.9 | 13.2 | 8 | + |
| 4 | 57.7 | 71.4 | 13.7 | 9 | + |
| 8 | 33.6 | 51.3 | 17.7 | 10 | + |
Critical values for the Wilcoxon signed rank test with a sample size of 10
| 0.10 | 0.05 | 0.01 | |
| Critical value | 10 | 8 | 3 |
Steps required in performing the Wilcoxon rank sum (Mann–Whitney) test
| Step | Details |
| 1 | Rank all observations in increasing order of magnitude, ignoring which group they come from. If two observations have the same magnitude, regardless of group, then they are given an average ranking |
| 2 | Add up the ranks in the smaller of the two groups (S). If the two groups are of equal size then either one can be chosen |
| 3 | Calculate an appropriate |
Total propofol doses in patients with a 3 to 5 day stay in the intensive care unit
| Nonprotocolized group | Protocolized group | ||
| Dose (g) | Rank | Dose (g) | Rank |
| 7.2 | 2 | 5.6 | 1 |
| 15.7 | 4 | 14.6 | 3 |
| 19.1 | 6 | 18.2 | 5 |
| 21.6 | 7.5 | 21.6 | 7.5 |
| 26.8 | 10 | 23.1 | 9 |
| 27.4 | 11 | 28.3 | 12 |
| 28.5 | 13 | 31.7 | 14 |
| 32.8 | 16 | 32.4 | 15 |
| 36.3 | 17 | 36.8 | 18 |
| 43.2 | 19 | ||
| 44.7 | 20 | ||
| S = 84.5 | |||
Critical values for the Wilcoxon rank sum test with sample sizes of 9 and 11
| 0.05 | 0.01 | 0.001 | |
| Critical value | 68–121 | 61–128 | 53–136 |